scispace - formally typeset
S

Shlomo Vinker

Researcher at Tel Aviv University

Publications -  220
Citations -  5792

Shlomo Vinker is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 31, co-authored 189 publications receiving 4435 citations. Previous affiliations of Shlomo Vinker include Medical Corps & Clalit Health Services.

Papers
More filters
Journal ArticleDOI

Adolescent BMI trajectory and risk of diabetes versus coronary disease.

TL;DR: An elevated BMI in adolescence--one that is well within the range currently considered to be normal--constitutes a substantial risk factor for obesity-related disorders in midlife, supporting the hypothesis that the processes causing incident coronary heart disease and diabetes are more gradual than those resulting in incident diabetes.
Journal ArticleDOI

Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study.

TL;DR: It is concluded that low plasma 25(OH)D levels appear to be an independent risk factor for COVID‐19 infection and hospitalization.
Journal ArticleDOI

A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study

TL;DR: A large number of patients with type 2 diabetes mellitus are obese and the appropriate dietary intervention for overweight persons with DM2 is unclear, and trials comparing the effectiveness of diets are frequently limited by short follow‐up times and high dropout rates.
Journal ArticleDOI

Dry eye in diabetic patients.

TL;DR: Ocular lubrication consumption increased with poorer glycemic control (mean annual HbA1c levels), and Multivariate analysis revealed this effect to be independent of age, sex, place of birth, or place of residence.
Journal ArticleDOI

Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

TL;DR: Physicians' knowledge was relatively low, and they assign much more importance to the physical fears of patients and are not sufficiently aware of patients' misconceptions regarding the seriousness of their condition and concerns of addiction, which contributes to the delay or even the prevention of commencing insulin medication.